Nevimune Tablet
By Nevimune
Rx
10 Tablet in a Strip

Composition
Nevirapine(200mg)

Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Expires on or after
October, 2025

liver
When using Nevimune Tablet, it is essential to exercise caution if you have liver disease. Patients with liver issues may require adjustments to their Nevimune Tablet dosage. Please seek advice from your doctor before using this medication. It is not advisable to use Nevimune Tablet in individuals with moderate to severe liver disease. It is recommended to undergo regular monitoring of liver function tests while on this medication. Nevimune Tablet 60's have the potential to cause severe liver damage, which can be life-threatening. Inform your doctor if you have a history of liver conditions, especially hepatitis B or C. If you have or had a liver illness, your doctor will likely instruct you to avoid taking Nevimune Tablet 60's.

kidney
Nevimune Tablet is generally safe for individuals with kidney disease. No dose adjustment is needed. However, inform your doctor of any kidney issues, especially if undergoing dialysis treatment.

alcohol
Caution is advised against consuming alcohol while taking Nevimune Tablet. Alcohol intake can increase the risk of stomach or intestine bleeding. Please consult your doctor.

driving
When taking Nevimune Tablet, be cautious as it may cause fatigue, impacting your ability to drive. Avoid driving vehicles after using Nevimune Tablet 60's.

pregnancy
Nevimune Tablet is generally safe to use during pregnancy. Limited human studies show low risks to the baby. Inform your doctor if pregnant or suspect pregnancy before taking. Your doctor will recommend a suitable dose to prevent HIV transmission.

breastfeeding
Nevimune Tablet is considered safe during breastfeeding based on limited human data. However, Nevimune Tablet 60's is excreted in milk, so if you have HIV or are taking Nevimune Tablet 60's, it is advised not to breastfeed your baby.
Habit Forming | No |
Chemical Class | Non-nucleoside analog |
Therapeutic Class | - |
Action Class | Non-Nucleoside reverse transcriptase inhibitors (NNRTIs) |
₹157.29
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 11-Feb-2025